Thu, May 28, 2020

Esther Rajavelu Maintained (ALNY) at Hold with Increased Target to $122 on, May 28th, 2020

Esther Rajavelu of UBS, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $111 to $122 on, May 28th, 2020.

Esther has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Luca Issi of "RBC Capital" Initiated at Hold and Held Target at $150 on, Wednesday, May 13th, 2020
  • Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Increased Target to $137 on, Thursday, May 7th, 2020


These are the ratings of the 6 analyists that currently disagree with Esther


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $162 on, Thursday, May 7th, 2020
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $171 on, Thursday, May 7th, 2020
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $156 on, Thursday, May 7th, 2020
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $162 on, Thursday, May 7th, 2020
  • Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $160 on, Wednesday, May 6th, 2020
  • Christopher Marai of "Nomura" Maintained at Sell and Held Target at $74 on, Tuesday, April 14th, 2020